Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Hot Flashes 1

Interventions

Gabapentin 3liposomal amphotericin B 2oxybutynin 1fezolinetant 1black cohosh root extract 1Venlafaxine Hydrochloride 1Vancomycin 1Testosterone 1Tazobactam 1Tamoxifen 1Tablets 1Sugars 1Soybean Proteins 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Levofloxacin 1Isoflavones 1Hypnosis 1Goserelin 1Folic Acid 1Filgrastim 1Estrogens, Conjugated (USP) 1Estradiol 1Cyproterone Acetate 1Citalopram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hot Flashes × Isoflavones × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡